Register for IndieBio New York’s Investor Showcase – March 11, 2026

Learn more about investing in Gilly Bio

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
Gilly Bio
Better, cheaper animal feed
Founded
2025
Employees*
2-10
Funding to Date*
$325,000
Website
gillybio.com
* Data source: Crunchbase
Dr, Boyan Xu, Co-Founder & CEO
On a per cow basis, we can save farmers 50 cents per cow per day while we earn 50 cents per cow per day in revenue.
Extremely low capex: $100K yields $1.3M revenue.

In the $600 Billion commodity animal feed market, farmers are being squeezed from all angles. As feed prices continue to rise, they are desperate for solutions to lower their input costs while still maintaining animal health and performance. Gilly takes large volume agricultural byproducts which are already being used in feed at low inclusion rates, and processes them to have higher protein and better digestibility with minimal added opex. In just a 3 day cycle they can boost protein content in the feedstock by at least 40% Essentially, Gilly can turn varied agricultural byproducts into feed with the same nutritional quality as a bulk feed like soybean meal.

In our lab, Gilly has proven they can upcycle soybean hulls, tomato pomace, distillers grain, corn silage, almond hulls, and more. Gilly will deploy their technology in a distributed manner on large farms and colocate with feedstock suppliers, optimizing for minimal transportation costs.

A massive industry also necessitates massive scale. Gilly’s first market is feeding the 1.7M dairy cows in California. Already at ton scale, Gilly is initiating a feed trial in 130 cows with a Modesto dairy, where they will evaluate the impacts of their feed on palatability and milk production. They’ll be treating a fraction of the 3 tons of dry feed these animals eat per day. Success with just this one customer will unlock a 7 figure revenue opportunity. Cofounders Bo and Vince have deep expertise in both operating commercial scale farming operations and scaling biomanufacturing processes for large volume markets.